.INVESTIGATION FEATURE.06 August 2024.
A sizable randomized regulated trial with cisgender ladies highlights the challenges of obedience to an everyday dental preexposure treatment program as well as illustrates that twice-yearly treatment of lenacapavir can easily maintain efficient HIV prevention levels over 6 months.